Skip to main content
Back
Watch Compare

MapLight Therapeutics, Inc.

Data quality: 83%
MPLT
Nasdaq Manufacturing Chemicals
$26.73
▼ $2.68 (-9.11%)
Mkt Cap: 1.31 B
Price
$28.77
Mkt Cap
1.31 B
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -138.61 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-35.16%
Above sector avg (-53.47%)
ROIC-28.83%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio13.22
Interest CoverageN/A

Valuation

PE (TTM)
-8.10
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -8.1 -1.5
P/B — 1.6
ROE % -35.2 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

6 analysts
Buy
Current
$26.73
+22.2%
Target
$32.67
$28.00
$33.00
$37.00
Forecast
Forward P/E -7.15
Forward EPS -$3.74
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$3.74
-$4.17 – -$3.25
 0.0 3
FY2026 -$4.61
-$5.75 – -$3.45
 0.0 3

Earnings Surprises

Last 2 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.83 -$2.47 -197.6%
Q32025 -$1.73 -$37.18 -2055.4%

ETFs Holding This Stock

IRSIX IRSIX
0.01% weight
IIRSX IIRSX
0.01% weight
IRCIX IRCIX
0.01% weight
VVICX VVICX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -161.15 M
ROE -35.16% ROA -33.61%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -138.61 M
ROIC -28.83% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 13.22
Interest Coverage N/A Asset Turnover N/A
Working Capital 226.74 M Tangible Book Value -274.18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8.10 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10.62%
Market Cap 1.31 B Enterprise Value 1.24 B
Per Share
EPS (Diluted TTM) -18.56 Revenue / Share N/A
FCF / Share -3.05 OCF / Share -3.04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86.01%
SBC-Adj. FCF -174.62 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue —
Net Income -161.15 M
EPS (Diluted) -18.56
Gross Profit —
Operating Income -169.08 M
EBITDA —
R&D Expenses 138.35 M
SG&A Expenses —
D&A —
Interest Expense —
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 479.51 M
Total Liabilities 21.14 M
Shareholders' Equity 458.37 M
Total Debt —
Cash & Equivalents 46.73 M
Current Assets 324.67 M
Current Liabilities 16.23 M